PhenX - reproductive history - female protocol 101301

General Details:

Name:
PhenX - reproductive history - female protocol 101301
Steward:
LOINC
Definition:
The female participant is first asked how many pregnancies she has had. If none, the protocol is complete. For each pregnancy she reports, she is asked a series of questions (e.g., whether pregnancy was a live birth, how long the pregnancy lasted, when did the pregnancy end, whether the participant had frequent nausea or vomiting). The participant is also asked about smoking and drinking during pregnancy. Female: If the participant answers with a number greater than zero to question 1, the interviewer should complete the rest of the protocol. If the participant answers "none" then the protocol is deemed complete. For question 3 (gestational age) the WG notes that a term pregnancy is 40 weeks. As noted above, this measure can also be used for estimating certain in utero exposures if the research subject is an infant. In that instance, the questions would be asked of the mother regarding her exposures to smoking and alcohol while pregnant with this child. The PhenX Working Group recommends that for that purpose, use only questions 3-15 and only for that pregnancy. For Question 4 interviewer should supply the respondent with a calendar. The PhenX Reproductive Health Working Group (WG) added the word "preeclampsia" to question 7 so that it now reads, "Preeclampsia/Toxemia." The PhenX Reproductive Health Working Group notes that for question 7, vaginal bleeding is a common, potentially important complication and should be asked specifically in 1st, 2nd and/or 3rd trimester. The WG removed the WISH question regarding pregnancy weight gain as it is included in the PhenX Toolkit, Anthropometric measure (Pregnancy Weight Gain). The original text for question 15 was placed below to provide toolkit users with its original format:
Registration Status:
Qualified

Designations:

Designation:
PhenX - reproductive history - female protocol 101301
Tags:
Long Common Name
Designation:
Reproductive history female proto
Tags:
Short Name

Designations:

Definition:
The female participant is first asked how many pregnancies she has had. If none, the protocol is complete. For each pregnancy she reports, she is asked a series of questions (e.g., whether pregnancy was a live birth, how long the pregnancy lasted, when did the pregnancy end, whether the participant had frequent nausea or vomiting). The participant is also asked about smoking and drinking during pregnancy. Female: If the participant answers with a number greater than zero to question 1, the interviewer should complete the rest of the protocol. If the participant answers "none" then the protocol is deemed complete. For question 3 (gestational age) the WG notes that a term pregnancy is 40 weeks. As noted above, this measure can also be used for estimating certain in utero exposures if the research subject is an infant. In that instance, the questions would be asked of the mother regarding her exposures to smoking and alcohol while pregnant with this child. The PhenX Working Group recommends that for that purpose, use only questions 3-15 and only for that pregnancy. For Question 4 interviewer should supply the respondent with a calendar. The PhenX Reproductive Health Working Group (WG) added the word "preeclampsia" to question 7 so that it now reads, "Preeclampsia/Toxemia." The PhenX Reproductive Health Working Group notes that for question 7, vaginal bleeding is a common, potentially important complication and should be asked specifically in 1st, 2nd and/or 3rd trimester. The WG removed the WISH question regarding pregnancy weight gain as it is included in the PhenX Toolkit, Anthropometric measure (Pregnancy Weight Gain). The original text for question 15 was placed below to provide toolkit users with its original format:
Tags:
Source: Regenstrief LOINC

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
en-US
Document:
National Cancer Institute. Women's Interview Study of Health. Question numbers B1- B8, B10 (question 1-9).
ID:
Title:
URI:
Provider Org:
Language Code:
en-US
Document:
Centers for Disease Control & Prevention. Pregnancy Risk Assessment Monitoring System(PRAMS). 2009. Phase 6 Core Questionnaire. Questions 26 (question 9), 27 (question 10), 31a (question 11), 31b (question 12), 32a (question 13), 32b (question 14).
ID:
Title:
URI:
Provider Org:
Language Code:
en-US
Document:
Centers for Disease Control & Prevention. Pregnancy Risk Assessment Monitoring System(PRAMS). 2004-2008. Phase 5 Standard Questions. Question V12 (question 15).
ID:
Title:
URI:
Provider Org:
Language Code:
en-US
Document:
Centers for Disease Control & Prevention. Pregnancy Risk Assessment Monitoring System¿(PRAMS). 2009. Phase 6 Core Questionnaire. (available at: http://www.cdc.gov/PRAMS/References/Phase6MailCore_FINAL.doc). Accessed December 31, 2009.
ID:
Title:
URI:
Provider Org:
Language Code:
en-US
Document:
National Cancer Institute. Women's Interview Study of Health. (available at: http://seer.cancer.gov/studies/epidemiology/study15.html). Accessed December 31, 2009.

Properties:

Key:
Related Names
Value:
HxPanPanel
PANEL.PHENXPanlPnl
Point in timeRandomReproductive history female proto
Key:
Related Codes
Value:
Code SystemCodeCode TextCode Version
https://www.phenxtoolkit.org101301reproductive_history___female
Key:
Fully-Specified Name
Value:
ComponentPropertyTimeSystemScaleMethod
PhenX - reproductive history - female protocol 101301-Pt^Patient-PhenX
Key:
Basic Attributes
Value:
ClassTypeFirst ReleasedLast UpdatedChange ReasonPanel Type
PANEL.PHENXClinicalVersion 2.36Version 2.66Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.Panel

Identifiers:

Source:
NLM
Id:
K5T1TmkDSu
Version:
1.0
Source:
LOINC
Id:
62672-1
Version:
2.69